D.E. Shaw & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-89,515
| Closed | -$7.63M | – | 4679 |
|
|
2025
Q4 | $7.63M | Buy |
+89,515
| New | +$7.35M | ﹤0.01% | 1985 |
|
|
2025
Q3 | – | Sell |
-171,204
| Closed | -$13.4M | – | 4661 |
|
|
2025
Q2 | $13.4M | Sell |
171,204
-703,202
| -80% | -$52.4M | 0.01% | 1280 |
|
|
2025
Q1 | $63.4M | Sell |
874,406
-102,412
| -10% | -$7.33M | 0.06% | 406 |
|
|
2024
Q4 | $72.3M | Sell |
976,818
-6,398
| -0.7% | -$448K | 0.05% | 432 |
|
|
2024
Q3 | $64.9M | Buy |
983,216
+893,566
| +997% | +$64.9M | 0.06% | 413 |
|
|
2024
Q2 | $8.28M | Sell |
89,650
-177,934
| -66% | -$15.8M | 0.01% | 1456 |
|
|
2024
Q1 | $25.6M | Buy |
267,584
+27,795
| +12% | +$2.33M | 0.02% | 793 |
|
|
2023
Q4 | $18.3M | Sell |
239,789
-183,440
| -43% | -$12.8M | 0.02% | 990 |
|
|
2023
Q3 | $29.3M | Sell |
423,229
-84,632
| -17% | -$6.8M | 0.03% | 652 |
|
|
2023
Q2 | $47.9M | Sell |
507,861
-2,520,545
| -83% | -$219M | 0.05% | 451 |
|
|
2023
Q1 | $251M | Buy |
3,028,406
+218,112
| +8% | +$17.1M | 0.27% | 52 |
|
|
2022
Q4 | $210M | Buy |
2,810,294
+2,367,796
| +535% | +$182M | 0.23% | 63 |
|
|
2022
Q3 | $36.6M | Buy |
442,498
+414,199
| +1,464% | +$39.9M | 0.04% | 529 |
|
|
2022
Q2 | $2.69M | Buy |
28,299
+9,906
| +54% | +$1.03M | ﹤0.01% | 2809 |
|
|
2022
Q1 | $2.17M | Sell |
18,393
-34,604
| -65% | -$3.88M | ﹤0.01% | 3212 |
|
|
2021
Q4 | $6.87M | Sell |
52,997
-180,423
| -77% | -$21M | 0.01% | 2045 |
|
|
2021
Q3 | $26.4M | Sell |
233,420
-281,725
| -55% | -$32.2M | 0.02% | 853 |
|
|
2021
Q2 | $53.4M | Sell |
515,145
-528,706
| -51% | -$49.8M | 0.05% | 508 |
|
|
2021
Q1 | $87.3M | Buy |
1,043,851
+824,058
| +375% | +$69.7M | 0.08% | 275 |
|
|
2020
Q4 | $20.1M | Sell |
219,793
-503,450
| -70% | -$41.8M | 0.02% | 955 |
|
|
2020
Q3 | $57.7M | Sell |
723,243
-248,142
| -26% | -$19.4M | 0.06% | 371 |
|
|
2020
Q2 | $67.1M | Sell |
971,385
-206,529
| -18% | -$14.7M | 0.08% | 282 |
|
|
2020
Q1 | $74.1M | Buy |
1,177,914
+1,040,259
| +756% | +$75M | 0.12% | 194 |
|
|
2019
Q4 | $10.7M | Buy |
137,655
+88,953
| +183% | +$6.95M | 0.01% | 1154 |
|
|
2019
Q3 | $3.57M | Sell |
48,702
-164,022
| -77% | -$11.5M | ﹤0.01% | 1897 |
|
|
2019
Q2 | $13.1M | Buy |
212,724
+164,148
| +338% | +$9.93M | 0.02% | 988 |
|
|
2019
Q1 | $3.1M | Sell |
48,576
-16,461
| -25% | -$939K | ﹤0.01% | 1857 |
|
|
2018
Q4 | $3.32M | Sell |
65,037
-409,794
| -86% | -$20.7M | ﹤0.01% | 1777 |
|
|
2018
Q3 | $27.6M | Sell |
474,831
-750,501
| -61% | -$36.7M | 0.03% | 634 |
|
|
2018
Q2 | $59.5M | Sell |
1,225,332
-221,205
| -15% | -$10.3M | 0.08% | 317 |
|
|
2018
Q1 | $67.3M | Buy |
1,446,537
+541,530
| +60% | +$23.5M | 0.09% | 268 |
|
|
2017
Q4 | $34M | Buy |
905,007
+176,835
| +24% | +$6.49M | 0.05% | 461 |
|
|
2017
Q3 | $26.5M | Buy |
728,172
+562,269
| +339% | +$21.4M | 0.04% | 508 |
|
|
2017
Q2 | $6.54M | Buy |
+165,903
| New | +$6.06M | 0.01% | 1154 |
|
|
2016
Q3 | – | Sell |
-866,250
| Closed | -$32.6M | – | 3413 |
|
|
2016
Q2 | $28.8M | Buy |
866,250
+827,253
| +2,121% | +$28.3M | 0.05% | 426 |
|
|
2016
Q1 | $1.15M | Buy |
+38,997
| New | +$1.08M | ﹤0.01% | 2267 |
|
|
2015
Q3 | – | Sell |
-47,790
| Closed | -$1.15M | – | 3765 |
|
|
2015
Q2 | $1.13M | Sell |
47,790
-1,851,924
| -97% | -$41.8M | ﹤0.01% | 2611 |
|
|
2015
Q1 | $45.1M | Sell |
1,899,714
-614,886
| -24% | -$13.8M | 0.07% | 335 |
|
|
2014
Q4 | $53.4M | Buy |
2,514,600
+1,415,814
| +129% | +$28.4M | 0.07% | 335 |
|
|
2014
Q3 | $18.7M | Buy |
1,098,786
+836,244
| +319% | +$13.2M | 0.02% | 737 |
|
|
2014
Q2 | $3.76M | Buy |
262,542
+62,568
| +31% | +$848K | 0.01% | 1820 |
|
|
2014
Q1 | $2.47M | Sell |
199,974
-178,272
| -47% | -$2.06M | ﹤0.01% | 2181 |
|
|
2013
Q4 | $4.15M | Sell |
378,246
-3,646,812
| -91% | -$41.1M | 0.01% | 1855 |
|
|
2013
Q3 | $46.7M | Buy |
4,025,058
+2,510,340
| +166% | +$29.4M | 0.07% | 287 |
|
|
2013
Q2 | $17M | Buy |
+1,514,718
| New | +$17.9M | 0.03% | 589 |
|
Other funds holding EW
D.E. Shaw & Co's EW Position: Q1 2026 in Review
D.E. Shaw & Co sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89,515 shares — an estimated $7.63M sold.
D.E. Shaw & Co first reported a position in EW in Q2 2013 and held it in 45 quarters. The position peaked at $251M in Q1 2023. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- D.E. Shaw & Co reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
- D.E. Shaw & Co sold 89,515 Edwards Lifesciences shares in Q1 2026, an estimated $7.63M.
- D.E. Shaw & Co first reported a position in Edwards Lifesciences in Q2 2013 and held it in 45 quarters.
- D.E. Shaw & Co's Edwards Lifesciences position peaked at $251M in Q1 2023.
- 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.